| Trademark Snap Shot Amendment & Mail Processing Stylesheet (Table presents the data on Amendment & Mail Processing Complete) |
|||
OVERVIEW |
|||
| SERIAL NUMBER | 88468906 | FILING DATE | 06/11/2019 |
| REG NUMBER | 0000000 | REG DATE | N/A |
| REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
| INTL REG # | N/A | INTL REG DATE | N/A |
| TM ATTORNEY | BUONGIORNO, CHRISTOPHE |
L.O. ASSIGNED | 102 |
PUB INFORMATION |
|||
| RUN DATE | 03/11/2020 | ||
| PUB DATE | N/A | ||
| STATUS | 661-RESPONSE AFTER NON-FINAL-ACTION-ENTERED | ||
| STATUS DATE | 03/10/2020 | ||
| LITERAL MARK ELEMENT | VECTIVBIO | ||
| DATE ABANDONED | N/A | DATE CANCELLED | N/A |
| SECTION 2F | NO | SECTION 2F IN PART | NO |
| SECTION 8 | NO | SECTION 8 IN PART | NO |
| SECTION 15 | NO | REPUB 12C | N/A |
| RENEWAL FILED | NO | RENEWAL DATE | N/A |
| DATE AMEND REG | N/A | ||
FILING BASIS |
|||||
| FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
| 1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
| 1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
| 44D | YES | 44D | YES | 44D | NO |
| 44E | NO | 44E | YES | 44E | NO |
| 66A | NO | 66A | NO | ||
| NO BASIS | NO | NO BASIS | NO | ||
MARK DATA |
|
| STANDARD CHARACTER MARK | YES |
| LITERAL MARK ELEMENT | VECTIVBIO |
| MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
| COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
| PARTY TYPE | 10-ORIGINAL APPLICANT |
| NAME | Dikean Management AG |
| ADDRESS | c/o Therachon AG Aeschenvorstadt 36 Basel, 4051 |
| ENTITY | 03-CORPORATION |
| CITIZENSHIP | Switzerland |
GOODS AND SERVICES |
|
| INTERNATIONAL CLASS | 001 |
| DESCRIPTION TEXT | Plant extracts for medical and pharmaceutical research purposes |
| INTERNATIONAL CLASS | 005 |
| DESCRIPTION TEXT | Nutritional additives for medical purposes in the nature of natural food extracts derived from herbs, fruits, spices, vegetables, algae, fungi; Nutritional additives for medical purposes in the nature of mineral preparations for medical use, trace-elements for medical purposes, vitamins, micronutrients preparations for the prevent of autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; phytopharmaceuticals for the treatment of autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; active plant agents; plant extracts for medical purposes; pharmaceutical and veterinary preparations for the treatment of human diseases; sanitary preparations for medical use; dietetic food, namely, herbs, fruits, spices, vegetables, algae, fungi; dietetic food, namely mineral preparations for medical purposes, trace-elements for medical purposes, vitamins, micro-nutrients adapted for medical use, food for babies; adjuvants for medical purposes; amino acids for medical purposes; anaesthetics; analgesics; vermifuges; antibiotics; biological preparations for the treatment of human diseases; chemical active components for medical use, namely, chemical preparations for treating genetic conditions, rare diseases and conditions, namely autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; chemical reagents for medical or veterinary purposes; chemico-pharmaceutical preparations for the treatment of human diseases; ferments for pharmaceutical purposes; hormones for medical purposes; medical infusions for the treatment of human diseases; medicines for the treatment of gum disease, caries, toothache and wound healing of the gums; medicines for the treatment of human diseases; radiological contrast substances for medical purposes; steroid; Medical and surgical apparatus and instruments, namely, orthopedic fixation device used in orthopedic transplant and/or implant surgery |
| INTERNATIONAL CLASS | 010 |
| DESCRIPTION TEXT | Surgical apparatus and instruments; medical diagnostic apparatus; Surgical apparatus and instruments for medical or veterinary use; Surgical and medical apparatus and instruments for use in orthopedic surgery; Medical instruments, namely, orthopedic apparatus and instruments; Medical and surgical apparatus and instruments, namely, orthopedic apparatus and instruments for diagnostic and therapeutic use; apparatus, devices and instruments for treating genetic conditions, rare diseases and conditions, namely autoimmune, immune, viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and intestinal, bowel diseases, disorders and conditions; orthopaedic articles, namely, orthopedic devices for diagnostic and therapeutic use; orthopaedic articles, namely, vertebral orthopedic apparatus; suture materials; therapeutic and assistive devices adapted for the disabled, namely motion sensing apparatus and assisted machines for the rehabilitation of hands and wrists, feet and ankles, knees, spine affected by neuromuscular diseases, disorders, or injuries for home or clinical use; massage apparatus; apparatus, devices and articles for nursing infants |
| INTERNATIONAL CLASS | 042 |
| DESCRIPTION TEXT | Scientific research, technological development of new products for others; medical research; scientific and industrial research in the fields of biotechnology, biology, rare diseases and conditions, genetic conditions and treatments of rare diseases and conditions; industrial research in the field of biomedical and phytopharmaceutical engineering; pharmaceutical laboratory services; pharmaceutical research and development; scientific services, namely, development of drugs, active agents and vaccines; scientific services, namely, development of food supplements; development and preparation of pharmaceuticals and medicines and plant extracts for use in pharmaceutical preparations and medicines |
| INTERNATIONAL CLASS | 044 |
| DESCRIPTION TEXT | Consulting on medicines, namely medical and pharmaceutical consultation |
GOODS AND SERVICES CLASSIFICATION |
|||||||
| INTERNATIONAL CLASS | 001 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 010 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
| INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
| CHANGE IN REGISTRATION | NO |
FOREIGN INFORMATION |
|
| PRIORITY CLAIMED | SEC. 44(D) ON Switzerland |
| APPLICATION NO. | 07882/2019 |
| APPLICATION FILING DATE | 06/11/2019 |
| FOREIGN REG NO. | N/A |
| FOREIGN REG DATE | N/A |
| FOREIGN RNWL NUM | N/A |
| DATE OF FOREIGN RNWL | N/A |
| FOREIGN EXPIRATION | N/A |
| FOREIGN RNWL EXPIRATION | N/A |
PROSECUTION HISTORY |
||||
| DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
| 03/10/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 013 |
| 03/09/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 012 |
| 03/09/2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 011 |
| 09/10/2019 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 010 |
| 09/10/2019 | GNRT | F | NON-FINAL ACTION E-MAILED | 009 |
| 09/10/2019 | CNRT | R | NON-FINAL ACTION WRITTEN | 008 |
| 09/03/2019 | DOCK | D | ASSIGNED TO EXAMINER | 007 |
| 07/01/2019 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 006 |
| 07/01/2019 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 005 |
| 06/25/2019 | ALIE | A | ASSIGNED TO LIE | 004 |
| 06/24/2019 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 003 |
| 06/19/2019 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | 002 |
| 06/14/2019 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
| ATTORNEY | Stacey Halpern |
| CORRESPONDENCE ADDRESS | Stacey Halpern KNOBBE, MARTENS, OLSON & BEAR, LLP 2040 MAIN STREET, 14TH FLOOR IRVINE CA 92614 |
| DOMESTIC REPRESENTATIVE | Stacey Halpern |